Multifunctional Ebselen drug functions through the activation of DNA damage response and alterations in nuclear proteins.
Several studies have demonstrated that Ebselen is an anti-inflammatory and anti-oxidative agent. Contrary to this, studies have also shown a high degree of cellular toxicity associated with Ebselen usage, the underlying mechanism of which remains less understood. In this study we have attempted to identify a possible molecular mechanism behind the above by investigating the effects of Ebselen on Saccharomyces cerevisiae. Significant growth arrest was documented in yeast cells exposed to Ebselen similar to that seen in presence of DNA damaging agents (including methyl methane sulfonate [MMS] and hydroxy urea [HU]). Furthermore, mutations in specific lysine residues in the histone H3 tail (H3 K56R) resulted in increased sensitivity of yeast cells to Ebselen presumably due to alterations in post-translational modifications of histone proteins towards regulating replication and DNA damage repair. Our findings suggest that Ebselen functions through activation of DNA damage response, alterations in histone modifications, activation of checkpoint kinase pathway and derepression of ribonucleotide reductases (DNA repair genes) which to the best of our knowledge is being reported for the first time. Interestingly subsequent to Ebselen exposure there were changes in global yeast protein expression and specific histone modifications, identification of which is expected to reveal a fundamental cellular mechanism underlying the action of Ebselen. Taken together these observations will help to redesign Ebselen-based therapy in clinical trials.
Laboratory of chromatin Biology, Department of Biology, Indian Institute of Science Education and Research, Bhopal - 462023, India.
Gajendra K
GK
Azad
Shah Jaimin
SJ
Balkrishna
Narayanan
N
Sathish
Sangit
S
Kumar
Raghuvir S
RS
Tomar
D000975:Antioxidants / Q000494:pharmacology; D001393:Azoles / Q000494:pharmacology*; D004249:DNA Damage / Q000187:drug effects* / Q000502:physiology; D054833:Isoindoles; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D016566:Organoselenium Compounds / Q000494:pharmacology*; D012441:Saccharomyces cerevisiae / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism*
D000975:Antioxidants; D001393:Azoles; D054833:Isoindoles; D009687:Nuclear Proteins; D016566:Organoselenium Compounds; D029701:Saccharomyces cerevisiae Proteins; C042986:ebselen